Schedule 13G ownership disclosure
ATHIRA PHARMA INC
Common Stock · CUSIP: 04746L104
Event date: 2025-04-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Steven Michael Oliveira
Shares: 1,994,649.00 · Class: 5.109%
- Nemean Asset Management, LLC
Shares: 1,644,649.00 · Class: 4.212%
- South Ocean Capital Management LLC
Shares: 250,000.00 · Class: 0.006%
- South Ocean Capital LLC
Shares: 100,000.00 · Class: 0.003%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-035511
- Form type
- SCHEDULE 13G
- Filer
- Athira Pharma, Inc.
- CIK
- CIK 1620463
- Filed
- Apr 16, 2025
- Reporting period
- Apr 14, 2025
- Description
- Schedule 13G beneficial ownership